Found 6 matching trials
SPI-1005 for the Treatment of Patients With Meniere's Disease
PHASE2This study will evaluate the safety, efficacy, and Pharmacokinetics (PK) of...
SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
PHASE2Chemotherapy treatment with platinum based agents is well noted to cause ot...
Location
VA Puget Sound Health Care
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
PHASE1This study will evaluate the safety and efficacy of three dose levels of SP...
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
PHASE2The primary objective of this study is to determine the safety and efficacy...
Location
Medical University of South Carolina
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
PHASE2SPI-1005 is a novel oral drug that contains a glutathione peroxidase mimeti...
Location
University of Miami
Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
PHASE2Exposure to loud sounds can cause hearing loss. The purpose of this researc...
Location
University of Florida